DOR/ISL Phase III data underlines trend for shift towards two-drug STRs in HIV
A 96-week Phase III study in adults with HIV who were previously virologically suppressed on oral antiretroviral therapy (ART) has…
Analyst Comment
FDA reversal on mRNA-1010 could transform the seasonal influenza vaccines market
Greater intake of caffeinated coffee and tea lowers dementia
A dose of optimism: WHO prequalifies new oral polio vaccine
Obesity associated with increased infectious disease risk
Brazilian study shows increase in Covid-19-era substance abuse-related deaths
WHO analysis shows four in ten cancers could be prevented
Leishmaniasis on World NTD Day: persistent pockets in a low-incidence era
